Jounce Therapeutics (JNCE) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 112 people. Jounce Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 631.73 M. Jounce Therapeutics has 32.46 M outstanding shares of which 3.27 M shares are currently shorted by private and institutional investors with about 24.78 trading days to cover.
The company currently holds about 235.65 M in cash with (90.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.31.
Check Jounce Therapeutics Probability Of Bankruptcy